Results 221 to 230 of about 4,697,552 (378)
Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption [PDF]
Steven Warach, Lawrence L. Latour
openalex +1 more source
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves+3 more
wiley +1 more source
Reperfusion therapy for acute ischemic stroke: where are we in 2023? [PDF]
Martins SCO+15 more
europepmc +1 more source
Myocardial Reperfusion Injury: Etiology, Mechanisms, and Therapies [PDF]
John W. Hoffman+3 more
openalex +1 more source
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini+15 more
wiley +1 more source
Stressed systems: Stroke unit bed occupancy and impact on reperfusion therapy in acute ischemic stroke. [PDF]
Blauenfeldt RA, Damgaard D, Simonsen CZ.
europepmc +1 more source
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy+5 more
wiley +1 more source
Renal Ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy
Johanne Tremblay+11 more
openalex +1 more source